Silexion Therapeutics Files 8-K/A Amendment
Ticker: SLXNW · Form: 8-K/A · Filed: Jul 8, 2025 · CIK: 2022416
Sentiment: neutral
Topics: amendment, disclosure, corporate-actions
Related Tickers: SLXN
TL;DR
Silexion Therapeutics filed an amendment to an 8-K, updating previous disclosures.
AI Summary
Silexion Therapeutics Corp. filed an amendment (8-K/A) on July 8, 2025, to a previous report. The amendment pertains to "Other Events" and was filed as of July 8, 2025, with the earliest event date being July 7, 2025. The company, formerly known as Biomotion Sciences until May 6, 2024, is incorporated in the Cayman Islands and headquartered in Ramat Gan, Israel.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information, which could be material for investors tracking the company's disclosures.
Risk Assessment
Risk Level: low — This is a procedural filing (an amendment to a previous report) rather than a disclosure of new material events, suggesting a low immediate risk impact.
Key Players & Entities
- Silexion Therapeutics Corp. (company) — Registrant
- Biomotion Sciences (company) — Former company name
- July 8, 2025 (date) — Date of report and filing
- July 7, 2025 (date) — Earliest event reported
- May 6, 2024 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K/A filing?
This 8-K/A filing serves as an amendment to a previous report, indicating corrections or additions to previously disclosed information under the 'Other Events' section.
When was Silexion Therapeutics Corp. formerly known as?
Silexion Therapeutics Corp. was formerly known as Biomotion Sciences until May 6, 2024.
What is the jurisdiction of incorporation for Silexion Therapeutics Corp.?
Silexion Therapeutics Corp. is incorporated in the Cayman Islands.
Where is the principal executive office of Silexion Therapeutics Corp. located?
The principal executive offices of Silexion Therapeutics Corp. are located at 12 Abba Hillel Road, Ramat-Gan, Israel.
What is the earliest event date reported in this filing?
The earliest event date reported in this filing is July 7, 2025.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on July 8, 2025 regarding Silexion Therapeutics Corp (SLXNW).